Report Highlights
The global market for medication adherence systems and technologies should grow from $3.5 billion in 2020 to $6.0 billion by 2025 with a compound annual growth rate (CAGR) of 11.4% for the period of 2020-2025.
Report Includes
- 20 data tables and 16 additional tables
- An overview of the global markets and technologies for medication adherence
- Analyses of global market trends, with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Description of disease and economic burden, and cost and morbidity in chronic diseases such as cardiovascular diseases (CVD), musculoskeletal disorders, gastrointestinal/digestive diseases, and cancer
- Details about adherence measurement, medication adherence and non-economic factors and methods to improve medication adherence
- Market share analysis of the medication adherence markets based on product/services, disease and region
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size, and market forecast of the medication adherence systems markets
- Discussion on advantages of software and mobile applications, and effectiveness of smartphone adherence apps on the general population
- Information on key marketed and pipeline products, challenges to improving medication adherence with technology and future developments of the industry
- Insights into regulation and reimbursement scenarios including, U.S. FDA technical considerations, FDA policy for low-risk and general wellness devices and regulatory systems for medication adherence systems and applications
- A look at the key industry acquisitions, strategic alliances and market share analysis of the leading suppliers of the industry
- Comprehensive profiles of major players in the industry, including ActualMeds Corp., etectRx, Health Net Inc., MedaCheck, Omnicell Inc., and Philips Healthcare
Report Scope
Medication adherence systems include hardware-based systems (e.g., smart pill bottles, smart caps, automated pill dispensers, electronic trays, smart medical watches, smart medical alarms, wearable sensors and other packaging systems) and software-based internet applications (e.g., cloud-based databases, health programs, patient web portals, mobile medication management applications, etc.) designed to improve medication adherence associated with various chronic diseases. This report is an analytical business tool whose primary purpose is to provide a thorough evaluation of the global market for medication adherence. The study covers the following:
- Detailed description of medication adherence systems and technologies including software applications (apps).
- Demographics and cost burden of targeted chronic diseases.
- Market characterization, unmet need, market size and segmentation.
- Market drivers and restraints.
- Detailed market projections through 2025.
- Competition and market shares.
- Key marketed products along with information about their regulatory status.
- Strategic landscape (merger and acquisitions).
- Regulatory structure.
- Pricing and reimbursement.
- Observations and conclusions on the future of medication adherence systems and technologies.
- Profiles of market participants and associations.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets (HLC176E)
- Carbon Credits Market: Global Outlook (EGY200A)
- Drugs and Diagnostics for Hematological Disorders: Global Markets (PHM116C)
- Global Flame and Smoke Detectors Markets (MFG092A)
- Biodegradable Polymers: Global Markets and Technologies (PLS025K)
Report Highlights
The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021.
Report Includes
- 16 data tables and 24 additional tables
- An overview of the global medication adherence market
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021
- Evaluations of clinical needs, competitive landscape, unmet needs, regulatory structure, and future outlook
- Examinations of the product types and the disease applications for medication adherence, along with chronic disorders
- Evaluations of the market's dynamics, specifically growth drivers and restraints
- Profiles of major players in the industry
Related Reports
Pharmacy Automation: Technologies and Global Markets
The global market for pharmacy automation is estimated to increase from $7.8 billion in 2023 to reach $12.7 billion by 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023 through 2028.
mRNA: Therapeutics and Global Markets
The global market for mRNA therapeutics is expected to decline from $33 billion in 2023 to $21 billion by the end of 2028, at a compound annual growth rate (CAGR) of -8.6% during the forecast period of 2023-2028.
Continuous Glucose Monitoring (CGM): Technologies and Global Markets
The global CGM market should reach $20.7 billion by 2022 and $32.7 billion by 2027, with a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2022-2027.
Global Markets for Telemedicine Technologies
The global market for telemedicine technologies is estimated to increase from $72.4 billion in 2022 to reach $173.3 billion by 2027, with a compound annual growth rate (CAGR) of 19.1% from 2022 through 2027.
Recent Reports
Drugs and Diagnostics for Hematological Disorders: Global Markets
The global market for drugs and diagnostics for hematological disorders is expected to grow from $131.2 billion in 2024 and is projected to reach $189.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Chagas Disease: American trypanosomiasis Market
The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More